Medical Devices News and Research

RSS
Patient access to online GP records: an interview with Bob Zemke

Patient access to online GP records: an interview with Bob Zemke

UC San Diego School of Medicine study compares payments among different specialties

UC San Diego School of Medicine study compares payments among different specialties

Argon Medical Devices completes acquisition of three vascular products from Rex Medical

Argon Medical Devices completes acquisition of three vascular products from Rex Medical

FDA issues two final orders to strengthen requirements for transvaginal surgical mesh safety

FDA issues two final orders to strengthen requirements for transvaginal surgical mesh safety

True Wearables launches world's first wireless, fully disposable, single-use pulse oximeter

True Wearables launches world's first wireless, fully disposable, single-use pulse oximeter

Cleanliness validation for medical devices webinar hosted by Lucideon

Cleanliness validation for medical devices webinar hosted by Lucideon

Mindray's shareholder resolutions adopted at annual general meeting

Mindray's shareholder resolutions adopted at annual general meeting

UW-led effort aims to develop implantable devices that promote brain plasticity, reanimate paralyzed limbs

UW-led effort aims to develop implantable devices that promote brain plasticity, reanimate paralyzed limbs

HDM introduces firmware upgrade for Z1 Auto CPAP machine and Nitelog App for Android devices

HDM introduces firmware upgrade for Z1 Auto CPAP machine and Nitelog App for Android devices

New $8.5M research grant aims to address patients affected by severe hemophilia A

New $8.5M research grant aims to address patients affected by severe hemophilia A

HBI-8000 granted orphan drug designation in Japan for treatment of peripheral T-cell lymphoma

HBI-8000 granted orphan drug designation in Japan for treatment of peripheral T-cell lymphoma

CSL submits rIX-FP new drug application to Japan's Pharmaceuticals and Medical Devices Agency

CSL submits rIX-FP new drug application to Japan's Pharmaceuticals and Medical Devices Agency

Bio Light's IOPtiMate system approved in Canada for treatment of glaucoma

Bio Light's IOPtiMate system approved in Canada for treatment of glaucoma

Australian researchers develop new technique to combat chronic bacterial infections in hospitals

Australian researchers develop new technique to combat chronic bacterial infections in hospitals

GSI Group purchases SkyeTek assets for $2.6 million

GSI Group purchases SkyeTek assets for $2.6 million

Hospital-acquired infections prevention market in the U.S. to grow at CAGR of over 7% during 2015 - 2020

Hospital-acquired infections prevention market in the U.S. to grow at CAGR of over 7% during 2015 - 2020

New research project aims to develop a method to reduce risk of pressure sores in patients

New research project aims to develop a method to reduce risk of pressure sores in patients

Use of tumor-treating fields along with chemotherapy improves survival in patients with brain tumor

Use of tumor-treating fields along with chemotherapy improves survival in patients with brain tumor

WuXi forms strategic alliance with MedImmune to accelerate development of biologics portfolio in China

WuXi forms strategic alliance with MedImmune to accelerate development of biologics portfolio in China

ALPHAEON agrees to bring Zelegent's office-based Elevoplasty technology to sleep specialists

ALPHAEON agrees to bring Zelegent's office-based Elevoplasty technology to sleep specialists

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.